Recent Finacing
Recent Raise
Cancer Prevention Pharmaceuticals develops cancer chemoprevention drugs focused on CPP-1X/sul (eflornithine plus sulindac), targeting polyamine synthesis and inflammation, with ongoing Phase 3 trials in FAP and colon cancer survivors.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor